A small SBIR-funded company (Rockville, MD) building tools that predict chemical toxicity and synthesize the evidence — QSAR models plus literature mining. The software layer of “how do we screen the chemicals around us.” (Not to be confused with Insilico Medicine, the AI-drug-discovery company.) Founded by Thomas Luechtefeld.
